CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 5,302,063 | $11,452,000 | 6.70% |
| BVF INC/IL | 6,929,690 | $14,968,000 | 1.32% |
| Opaleye Management Inc. | 1,550,000 | $3,348,000 | 0.85% |
| CAXTON CORP | 197,459 | $427,000 | 0.40% |
| NEA Management Company, LLC | 3,750,000 | $8,100,000 | 0.35% |
| ALGERT GLOBAL LLC | 339,349 | $733,000 | 0.16% |
| Orbimed Advisors | 5,000,000 | $10,800,000 | 0.13% |
| Alambic Investment Management, L.P. | 35,665 | $77,000 | 0.06% |
| OXFORD ASSET MANAGEMENT LLP | 433,002 | $928,000 | 0.02% |
| SECTORAL ASSET MANAGEMENT INC | 32,241 | $70,000 | 0.01% |